Serina Therapeutics, Inc.

SER · NYSE
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$6-$5-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$1
Change in WC$1$1$0-$0
Other Non-Cash-$1$1-$1-$3
Operating Cash Flow-$4-$4-$4-$5
Investing Activities
PP&E Inv.-$0-$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0$0-$0
Financing Activities
Debt Repay.$5$0$0$0
Stock Issued$2$6$5$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$5
Financing Cash Flow$6$6$5$5
Forex Effect-$0$0$0$0
Net Chg. in Cash$3$2$1$0
Supplemental Information
Beg. Cash$6$4$4$3
End Cash$9$6$4$4
Free Cash Flow-$4-$4-$4-$5
Serina Therapeutics, Inc. (SER) Financial Statements & Key Stats | AlphaPilot